Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMarthin, June K.
dc.contributor.authorLucas, Jane S
dc.contributor.authorCasaulta, Carmen
dc.contributor.authorCrowley, Suzanne
dc.contributor.authorDestouches, Damien M.S.
dc.contributor.authorMoreno Galdó, Antonio
dc.contributor.authorBoon, Mieke
dc.date.accessioned2022-04-08T12:21:41Z
dc.date.available2022-04-08T12:21:41Z
dc.date.issued2021-07-01
dc.identifier.citationMarthin JK, Lucas JS, Boon M, Casaulta C, Crowley S, Destouches DMS, et al. International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives. ERJ Open Res. 2021 Jul;7(3):00301–2021.
dc.identifier.issn2312-0541
dc.identifier.urihttps://hdl.handle.net/11351/7337
dc.descriptionPrimary ciliary dyskinesia; Consensus; Infection prevention
dc.description.abstractIntroduction In primary ciliary dyskinesia (PCD) impaired mucociliary clearance leads to recurrent airway infections and progressive lung destruction, and concern over chronic airway infection and patient-to-patient transmission is considerable. So far, there has been no defined consensus on how to control infection across centres caring for patients with PCD. Within the BEAT-PCD network, COST Action and ERS CRC together with the ERN-Lung PCD core a first initiative has now been taken towards creating such a consensus statement. Methods A multidisciplinary international PCD expert panel was set up to create a consensus statement for infection prevention and control (IP&C) for PCD, covering diagnostic microbiology, infection prevention for specific pathogens considered indicated for treatment and segregation aspects. Using a modified Delphi process, consensus to a statement demanded at least 80% agreement within the PCD expert panel group. Patient organisation representatives were involved throughout the process. Results We present a consensus statement on 20 IP&C statements for PCD including suggested actions for microbiological identification, indications for treatment of Pseudomonas aeruginosa, Burkholderia cepacia and nontuberculous mycobacteria and suggested segregation aspects aimed to minimise patient-to-patient transmission of infections whether in-hospital, in PCD clinics or wards, or out of hospital at meetings between people with PCD. The statement also includes segregation aspects adapted to the current coronavirus disease 2019 (COVID-19) pandemic. Conclusion The first ever international consensus statement on IP&C intended specifically for PCD is presented and is targeted at clinicians managing paediatric and adult patients with PCD, microbiologists, patient organisations and not least the patients and their families.
dc.language.isoeng
dc.publisherEuropean Respiratory Society
dc.relation.ispartofseriesERJ Open Research;7(3)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectMalalties cròniques - Prevenció
dc.subjectMalalties transmissibles - Transmissió
dc.subjectInfeccions respiratòries en els infants
dc.subject.meshCiliary Motility Disorders
dc.subject.mesh/prevention & control
dc.subject.meshCommunicable Disease Control
dc.subject.meshChronic Disease
dc.titleInternational BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1183/23120541.00301-2021
dc.subject.decstrastornos de la motilidad ciliar
dc.subject.decs/prevención & control
dc.subject.decscontrol de enfermedades transmisibles
dc.subject.decsenfermedad crónica
dc.relation.publishversionhttps://doi.org/10.1183/23120541.00301-2021
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Marthin JK] Danish PCD Centre Copenhagen, Paediatric Pulmonary Service, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. [Lucas JS] Primary Ciliary Dyskinesia Centre, NIHR Respiratory Biomedical Research Centre, Clinical and Experimental Science, University of Southampton, Southampton, UK. [Boon M] Dept of Paediatrics, University Hospital Gasthuisberg, Leuven, Belgium. [Casaulta C] Division of Paediatric Respiratory Medicine, University Children’s Hospital, Bern, Switzerland. [Crowley S] Paediatric Dept of Allergy and Lung Diseases, Oslo University Hospital, Oslo, Norway. [Destouches DMS] Association des Patients Ayant une Dyskinésie Ciliaire Primitive, Limeil-Brevannes, France. [Moreno-Galdó A] Servei de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
dc.identifier.pmid34350277
dc.identifier.wos000684273900037
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record